This inventor holds 2 USPTO granted patents. Top assignees: University of California, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2005-2007.
Company Filing History:
2 out of 15,988 
1 out of 955 
Years Active: 2005-2007
Title: Michel Accad: Innovator in ACAT-2 Research
Introduction
Michel Accad is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the study of Acyl CoA:cholesterol acyltransferase (ACAT-2). With a total of 2 patents, his work has implications for both diagnostic and therapeutic applications.
Latest Patents
Accad's latest patents focus on nucleic acid compositions encoding novel ACAT proteins, specifically the ACAT-2 proteins. These patents detail methods for producing the nucleic acid and protein compositions. The polypeptide and nucleic acid compositions are designed for various applications, including diagnostic and therapeutic agent screening, as well as treatment therapies for conditions associated with ACAT-2 activity, such as gallstones.
Career Highlights
Throughout his career, Michel Accad has worked with prestigious institutions, including the University of California and the United States Government, represented by the Department of Veterans Affairs. His research has contributed to advancements in understanding cholesterol metabolism and its related disorders.
Collaborations
Accad has collaborated with esteemed colleagues, including Robert V Farese, Jr. and Sandra K Erickson. These partnerships have enhanced the depth and impact of his research in the field.
Conclusion
Michel Accad's innovative work in the area of ACAT-2 research has the potential to lead to significant advancements in medical treatments. His contributions continue to influence the landscape of biochemistry and therapeutic development.